Garenoxacin as a prophylactic anti-infective in hydropneumothorax: a case study report
Keywords:
Pneumothorax, Iatrogenic, Garenoxacin, Chest drainAbstract
Pneumothorax appears to be a common clinical state. Iatrogenic pneumothorax occurs commonly after procedures such as transthoracic needle biopsy, pleural biopsy, positive pressure ventilation, etc. Diagnosis of iatrogenic pneumothorax is often delayed. Broad spectrum anti-infectives appear to be beneficial in reducing the infections, especially when chest drains are inserted. Garenoxacin, a potent quinolone with its unique structural modification appears to have an edge over other respiratory quinolones.
References
MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65 Suppl 2:ii18-31.
Henry M, Arnold T, Harvey J, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003;58 Suppl 2:ii39-52.
Ghezel-Ahmadi D, Bölükbas S, Fischer T, Ghezel-Ahmadi V, Schirren J. Pneumothorax, what kind of therapy is necessary? A clinical overview. Zentralbl Chir. 2012;137(3):214-22.
Noppen M, De Keukeleire T. Pneumothorax. Respiration. 2008;76(2):121-7.
Loiselle A, Parish JM, Wilkens JA, Jaroszewski DE. Managing iatrogenic pneumothorax and chest tubes. J Hosp Med. 2013;8(7):402-8.
Withers JN, Fishback ME, Kiehl PV, Hannon JL. Spontaneous pneumothorax. Suggested etiology and comparison of treatment methods. Am J Surg. 1964;108:772-6.
Bense L, Eklund G, Wiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest. 1987;92(6):1009-12.
Grover FL, Richardson JD, Fewel JG, Arom KV, Webb GE, Trinkle JK. Prophylactic antibiotics in the treatment of penetrating chest wounds. A prospective double-blind study. J Thorac Cardiovasc Surg. 1977;74(4):528-36.